Skip to content
STRATUM

RESPIRERX PHARMACEUTICALS INC.

CIK 0000849636

Financial snapshot

Revenue
Net income
Operating margin
Free cash flow
Total debt
Cash

Research

Recent filings load as you scroll to this section.

Analytical signals

How signals work →

Calculations over this company’s filings, each compared with a stated threshold. They indicate where to read more closely; they are analytical evidence, not conclusions, and none implies wrongdoing.

Interest coverage

P-13 · Calculated

Threshold met

FY 2022-12-31

Whether operating earnings cover interest expense, and for how many consecutive years they did not.

Interest coverage below 1.0x for 4 consecutive years (BIS-style test; company age is not checked)

Trend: flat

No stored result for Earnings quality, Subsidiary jurisdictions, ESG disclosure support, Effective tax rate, Pension funding, Insider filing timing, Language change, Strategic-review language, Carbon-exposed assets, Restatement indicators. Some signals are computed on request, and others need inputs this company’s filings do not tag; a missing result is not a finding either way.

Methodology and sources

  • Financial figures come from SEC XBRL company facts (annual reports). Choose any evidence marker to see the filing behind a value.
  • Filing text comes from SEC EDGAR. Browse this company on EDGAR ↗
  • Signals are calculated by Stratum from those filings. Some use AI to read filing text, and every AI claim must quote the document verbatim or it is discarded. Full methodology

More tools: chat with the 10-K · generate an investigation memo